Literature DB >> 21311023

Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.

Annette Ives1, Catherine Ronet, Florence Prevel, Giulia Ruzzante, Silvia Fuertes-Marraco, Frederic Schutz, Haroun Zangger, Melanie Revaz-Breton, Lon-Fye Lye, Suzanne M Hickerson, Stephen M Beverley, Hans Acha-Orbea, Pascal Launois, Nicolas Fasel, Slavica Masina.   

Abstract

Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with chronic inflammation. Currently, the mechanisms involved in lesion development are poorly understood. Here we show that metastasizing parasites have a high Leishmania RNA virus-1 (LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune responses rendered mice more susceptible to infection, and the animals developed an increased footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host immune response to Leishmania and promoted parasite persistence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21311023      PMCID: PMC3253482          DOI: 10.1126/science.1199326

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  The role of nitric oxide in innate immunity.

Authors:  C Bogdan; M Röllinghoff; A Diefenbach
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

2.  Distribution and sequence divergence of LRV1 viruses among different Leishmania species.

Authors:  L Guilbride; P J Myler; K Stuart
Journal:  Mol Biochem Parasitol       Date:  1992-08       Impact factor: 1.759

3.  Infectivity of the subspecies of the Leishmania braziliensis complex in vivo and in vitro.

Authors:  J A Rey; B L Travi; A Z Valencia; N G Saravia
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

Review 4.  Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous Leishmaniasis.

Authors:  K Weigle; N G Saravia
Journal:  Clin Dermatol       Date:  1996 Sep-Oct       Impact factor: 3.541

5.  Behavior of Leishmania braziliensis s.l. in golden hamsters: evolution of the infection under different experimental conditions.

Authors:  B Travi; J Rey-Ladino; N G Saravia
Journal:  J Parasitol       Date:  1988-12       Impact factor: 1.276

6.  Clonal diversity in the expression and stability of the metastatic capability of Leishmania guyanensis in the golden hamster.

Authors:  J E Martínez; L Valderrama; V Gama; D A Leiby; N G Saravia
Journal:  J Parasitol       Date:  2000-08       Impact factor: 1.276

Review 7.  Tumour necrosis factor alpha and mucocutaneous leishmaniasis.

Authors:  J M Blackwell
Journal:  Parasitol Today       Date:  1999-02

8.  Retention and loss of RNA interference pathways in trypanosomatid protozoans.

Authors:  Lon-Fye Lye; Katherine Owens; Huafang Shi; Silvane M F Murta; Ana Carolina Vieira; Salvatore J Turco; Christian Tschudi; Elisabetta Ullu; Stephen M Beverley
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

9.  Characterization of a RNA virus from the parasite Leishmania.

Authors:  G Widmer; A M Comeau; D B Furlong; D F Wirth; J L Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Short report: quantification of leishmaniavirus RNA in clinical samples and its possible role in pathogenesis.

Authors:  Monica M Ogg; Ricardo Carrion; Ana Cristina de Carvalho Botelho; Wilson Mayrink; Rodrigo Correa-Oliveira; Jean L Patterson
Journal:  Am J Trop Med Hyg       Date:  2003-09       Impact factor: 2.345

View more
  157 in total

1.  [Mucocutaneous leishmaniasis and an undesired passenger].

Authors:  Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Med Sci (Paris)       Date:  2011-11-30       Impact factor: 0.818

2.  Metagenomics and personalized medicine.

Authors:  Herbert W Virgin; John A Todd
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

3.  Accounting for reciprocal host-microbiome interactions in experimental science.

Authors:  Thaddeus S Stappenbeck; Herbert W Virgin
Journal:  Nature       Date:  2016-06-09       Impact factor: 49.962

4.  Host-pathogen interaction: Culprit within a culprit.

Authors:  Martin Olivier
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

5.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 6.  Unveiling the pathogen behind the vacuole.

Authors:  Peter Liehl; Vanessa Zuzarte-Luis; Maria M Mota
Journal:  Nat Rev Microbiol       Date:  2015-07-20       Impact factor: 60.633

7.  Mucosal leishmaniasis: A Retrospective Study of 327 Cases from an Endemic Area of Leishmania (Viannia) braziliensis.

Authors:  Carolina Cincurá; Clara Mônica F de Lima; Paulo R L Machado; Jamary Oliveira-Filho; Marshall J Glesby; Marcus M Lessa; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

8.  UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major.

Authors:  Bruno Luiz Fonseca Schamber-Reis; Patricia M Petritus; Braulia C Caetano; Espiridion R Martinez; Kendi Okuda; Douglas Golenbock; Phillip Scott; Ricardo T Gazzinelli
Journal:  J Biol Chem       Date:  2013-01-16       Impact factor: 5.157

9.  Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.

Authors:  Matteo Rossi; Patrik Castiglioni; Mary-Anne Hartley; Remzi Onur Eren; Florence Prével; Chantal Desponds; Daniel T Utzschneider; Dietmar Zehn; Maria G Cusi; F Matthew Kuhlmann; Stephen M Beverley; Catherine Ronet; Nicolas Fasel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

10.  Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.

Authors:  Michelle A Favila; Nicholas S Geraci; Erliang Zeng; Brent Harker; David Condon; Rachel N Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.